Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Video Expert Opinion
Round Table Discussions
Sign in
Join now
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Roger Stupp MD
Roger Stupp MD Advisory Board
Benjamin Anderson MD, FACS
Benjamin O. Anderson MD, FACS Advisory Board
See All Experts
featured
Published in Oncology and
2 other channels

Expert Opinion / Interview · February 15, 2018

ASCO GU 2018: Enzalutamide vs Bicalutamide for Metastatic Hormone Sensitive Prostate Cancer

Farzanna Haffizulla MD, FACP, FAMWA
Ulka Vaishampayan MD
Interview with
Ulka Vaishampayan MD

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Ulka Vaishampayan MD

Further Reading

Related Videos